Sessions target audience: Pis / RC's / RegC's

With the improved health of people with Cystic Fibrosis and increased use of telehealth for clinical care, new strategies to limit the burden placed on them to participate in clinical trials is needed.  Over the last year, a group of investigators have been meeting to review outcome measures that can be measured remotely.  This session will describe key take home messages from this work, next steps for development and evaluation and limitations of remote monitoring